Auf dieser Seite
LGVN Klasse A Longeveron Inc. - Class A Common stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 12, 2026
$2,58
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,3052-Wochen-Tief
$12,3052-Wochen-Hoch
P/E (TTM)
-2.6
EPS (TTM)
$-1.00
Umsatz (TTM)
$1M
Ihre Abzeichen
52W-Spanne
$2–$12
Analystenbewertung
BUY
Kursziel
$61
P/E
-2.6
ROE
-203.6%
Nettogewinnmarge
-1977.6%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
LGVN Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.58
P/E (TTM)
-2.6
EPS (TTM)
$-1.00
Umsatz (TTM)
$1M
ROE (TTM)
-203.6%
52W-Spanne
$2–$12
LGVN Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 27. August 2026 | 1-for-10 | Umgekehrt |
| 27. März 2024 | 1-for-10 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$1M2020-12-31 → 2025-12-31
EPS$-1.292021-12-31 → 2025-12-31
Freier Cashflow$-19M2021-12-31 → 2025-12-31
Nettogewinnmarge-1977.6%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | LGVN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -2.65-Jahres-Durchschnitt ≈-34.5 | ≈-34.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | LGVN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 69.8%5-Jahres-Durchschnitt ≈57.9% | ≈57.9% | · | · | |
| Betriebsgewinnmarge (TTM) | -1992.8%5-Jahres-Durchschnitt ≈-1361.5% | ≈-1361.5% | -2298.3% | Im Einklang | |
| EBITDA-Marge (TTM) | -1925.4%5-Jahres-Durchschnitt ≈-1337.5% | ≈-1337.5% | -2260.7% | Im Einklang | |
| Nettogewinnmarge (TTM) | -1977.6%5-Jahres-Durchschnitt ≈-1352.0% | ≈-1352.0% | -2028.1% | Schwach | |
| ROA (TTM) | -145.6%5-Jahres-Durchschnitt ≈-82.7% | ≈-82.7% | -124.3% | Im Einklang | |
| ROE (TTM) | -203.6%5-Jahres-Durchschnitt ≈-113.9% | ≈-113.9% | -270.9% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | LGVN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.65-Jahres-Durchschnitt ≈6.5 | ≈6.5 | 1.8 | Starke Liquidität | |
| Quick Ratio | 1.25-Jahres-Durchschnitt ≈6.0 | ≈6.0 | 1.6 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | LGVN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -49.9%5-Jahres-Durchschnitt ≈12.5% | ≈12.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -0.63%5-Jahres-Durchschnitt ≈-9.4% | ≈-9.4% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -26.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | LGVN | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.0 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 12.85-Jahres-Durchschnitt ≈15.4 | ≈15.4 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$31.6K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-5.9%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-1.90 | $-1.78 | -6.4% |
| 31. März 2026 | Mai 13, 2026 | $-1.90 | $-1.68 | -12.9% |
| 31. Dezember 2025 | $-2.30 | $-4.23 | 45.7% | |
| 30. September 2025 | $-3.90 | $-2.60 | -49.9% | |
| 30. Juni 2025 | $-0.33 | $-0.36 | 8.2% | |
| 31. März 2025 | $-0.34 | $-0.33 | -1.8% | |
| 31. Dezember 2024 | $-0.43 | $-0.35 | -24.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $709.0K | $1M | $1M | $6M | |
| Cost of Revenue | $396.0K | $508.0K | $488.0K | $725.0K | $716.0K | $4M | |
| Gross Profit | $803.0K | $2M | $221.0K | $497.0K | $590.0K | $2M | |
| R&D Expense | $12M | $8M | $9M | $9M | $7M | $3M | |
| SG&A Expense | $12M | $10M | $12M | $8M | $10M | $3M | |
| Operating Expenses | $24M | $18M | $21M | $19M | $18M | $6M | |
| Operating Income | $-23M | $-17M | $-21M | $-18M | $-17M | $-4M | |
| Interest Expense | · | · | · | $1M | · | · | |
| Other Non-op | $680.0K | $549.0K | $-377.0K | $300.0K | $411.0K | $57.0K | |
| Income Tax | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-23M | $-16M | $-21M | $-19M | $-17M | $-4M | |
| EPS (Basic) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · | |
| EPS (Diluted) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · | |
| Shares (Basic) | 17,576,551,000 | 9,411,164,000 | 2,173,490,000 | 20,969,032 | 18,915,086 | · | |
| Shares (Diluted) | 17,576,551,000 | 9,411,164,000 | 2,173,490,000 | 20,969,032 | 18,915,086 | · | |
| EBITDA | $-22M | $-16M | · | $-18M | $-17M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $19M | $5M | $11M | $26M | $816.0K | |
| Short-term Investments | · | $0 | $412.0K | $9M | $9M | · | |
| Receivables | $104.0K | $84.0K | $111.0K | $218.0K | $55.0K | · | |
| Prepaid Expense | $686.0K | $308.0K | $376.0K | $404.0K | $282.0K | $52.0K | |
| Current Assets | $5M | $20M | $6M | $20M | $35M | $2M | |
| PP&E (Net) | $2M | $2M | $3M | $3M | $3M | $4M | |
| PP&E (Gross) | $8M | $8M | $7M | $7M | $6M | $6M | |
| Accum. Depreciation | $6M | · | · | · | $3M | $3M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $176.0K | $202.0K | $193.0K | $244.0K | · | · | |
| Total Assets | $10M | $26M | $12M | $27M | $43M | $9M | |
| Accounts Payable | $423.0K | $99.0K | $638.0K | $2M | $645.0K | $2M | |
| Accrued Liabilities | $3M | $2M | $2M | $650.0K | $1M | $2M | |
| Current Liabilities | $4M | $3M | $4M | $5M | $3M | $4M | |
| Capital Leases | $169.0K | $824.0K | $1M | $2M | · | · | |
| Other Non-current Liabilities | $330.0K | $265.0K | $0 | · | · | · | |
| Total Liabilities | $5M | $4M | $5M | $7M | $5M | $7M | |
| Long-term Debt | · | · | · | · | · | $311.0K | |
| Common Stock | · | · | · | $6.0K | $5.0K | · | |
| Paid-in Capital | $138M | $131M | $92M | $84M | $81M | · | |
| Retained Earnings | $-132M | $-110M | $-85M | $-63M | $-44M | · | |
| Treasury Stock | · | · | · | $100.0K | $100.0K | · | |
| AOCI | · | · | $0 | $-357.0K | · | · | |
| Stockholders' Equity | $6M | $22M | $7M | $21M | $37M | $2M | |
| Liabilities + Equity | $10M | $26M | $12M | $27M | $43M | $9M |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $800.0K | $700.0K | $700.0K | $700.0K | $1 | $1 | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $1M | $44.0K | |
| Amort. of Intangibles | $400.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | |
| Other Non-cash | $2M | $-923.0K | · | $5M | $6M | · | |
| Operating Cash Flow | $-19M | $-14M | $-19M | $-14M | $-10M | $-2M | |
| CapEx | $245.0K | $655.0K | $301.0K | $569.0K | $330.0K | $131.0K | |
| Investing Cash Flow | $-595.0K | $-640.0K | $8M | $-677.0K | $-11M | $-261.0K | |
| Stock Issued | $5M | $13M | $5M | $2.0K | $27M | · | |
| Net Stock Activity | $5M | $13M | · | · | $27M | · | |
| Financing Cash Flow | $5M | $29M | $5M | $-509.0K | $45M | $2M | |
| Taxes Paid | $0 | · | · | · | · | · | |
| Free Cash Flow | $-19M | $-15M | · | $-15M | $-10M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 67.0% | 78.8% | · | 40.7% | 45.2% | · | |
| Operating Margin | -1942.2% | -690.7% | · | -1476.5% | -1336.6% | · | |
| Net Margin | -1893.6% | -667.8% | · | -1541.3% | -1305.1% | · | |
| EBITDA Margin | -1875.5% | -661.4% | · | -1476.5% | -1336.6% | · | |
| ROA | -126.8% | -84.9% | · | -53.7% | -65.5% | · | |
| ROE | -247.7% | -67.2% | · | -83.5% | -57.0% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 7.6 | · | 4.2 | 13.1 | · | |
| Quick Ratio | 1.2 | 7.5 | · | 2.2 | 13.0 | · | |
| Interest Coverage | · | · | · | -12.9 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.0 | 0.1 | · | |
| Receivables Turnover | 12.8 | 24.5 | · | 9.0 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.00 | $0.00 | · | $0.06 | · | · | |
| Cash Flow / Share | $-0.00 | $-0.00 | · | $-0.67 | · | · | |
| EPS (TTM) | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -49.9% | 237.4% | -42.0% | -6.4% | -76.8% | · | |
| Revenue CAGR 3Y | -0.63% | 22.4% | -49.9% | · | · | · | |
| Revenue CAGR 5Y | -26.6% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $2M | $709.0K | $1M | $1M | $6M | |
| Net Income TTM | $-23M | $-16M | $-21M | $-19M | $-17M | $-4M | |
| P/E | -0.4 | -0.7 | -1.3 | -35.8 | -134.1 | · | |
| Earnings Yield | -254.9% | -151.4% | -75.1% | -2.8% | -0.75% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $287.0K | $398.0K | $365.0K | $137.0K | $316.0K | $381.0K | $603.0K | $773.0K | $468.0K | $548.0K | $63.0K | $150.0K | $217.0K | $279.0K | $121.0K | $265.0K | |
| Cost of Revenue | $105.0K | $134.0K | $108.0K | $12.0K | $170.0K | $106.0K | $74.0K | $91.0K | $124.0K | $219.0K | $65.0K | $96.0K | $124.0K | $203.0K | $41.0K | $173.0K | |
| Gross Profit | $182.0K | $264.0K | $257.0K | $125.0K | $146.0K | $275.0K | $529.0K | $682.0K | $344.0K | $329.0K | $-2.0K | $54.0K | $93.0K | $76.0K | $80.0K | $92.0K | |
| R&D Expense | $3M | $2M | $3M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| SG&A Expense | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $4M | $2M | $2M | $2M | |
| Operating Expenses | $6M | $5M | $6M | $7M | $6M | $5M | $5M | $5M | $4M | $4M | $5M | $5M | $6M | $5M | $5M | $5M | |
| Operating Income | $-6M | $-5M | $-5M | $-7M | $-5M | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-6M | $-5M | $-5M | $-5M | |
| Other Non-op | $98.0K | $39.0K | $52.0K | $89.0K | $369.0K | $170.0K | $200.0K | $230.0K | $87.0K | $32.0K | $-581.0K | $55.0K | $80.0K | $69.0K | $2M | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-6M | $-5M | $-5M | $-7M | $-5M | $-5M | $-4M | $-4M | $-3M | $-4M | $-6M | $-5M | $-6M | $-5M | $-4M | $-5M | |
| EPS (Basic) | $-0.19 | $-0.19 | $-0.23 | $-0.39 | $-0.33 | $-0.34 | $1.16 | $-0.34 | $-1.83 | $-1.61 | $-2.55 | $-2.79 | $-2.67 | $-2.21 | $-0.21 | $-0.25 | |
| EPS (Diluted) | $-0.19 | $-0.19 | $-0.23 | $-0.39 | $-0.33 | $-0.34 | $1.16 | $-0.34 | $-1.83 | $-1.61 | $-2.55 | $-2.79 | $-2.67 | $-2.21 | $-0.21 | $-0.25 | |
| Shares (Basic) | 31,377,630 | 24,786,282,000 | · | 18,373,198,000 | 15,013,072 | 14,950,734,000 | · | 13,627,793,000 | 6,509,881,000 | 2,513,587,000 | · | 2,117,877,000 | 2,110,544 | 2,103,362 | · | 21,001,613 | |
| Shares (Diluted) | 31,377,630 | 24,786,282,000 | · | 18,373,198,000 | 15,013,072 | 14,950,734,000 | · | 13,627,793,000 | 6,509,881,000 | 2,513,587,000 | · | 2,117,877,000 | 2,110,544 | 2,103,362 | · | 21,001,613 | |
| EBITDA | $-6M | $-5M | · | $-7M | $-5M | $-5M | · | $-5M | $-3M | $-4M | · | $-5M | $-6M | $-5M | · | $-5M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $16M | $5M | $9M | $10M | $14M | $19M | $23M | $12M | $2M | $5M | $2M | $3M | $5M | $11M | $14M | |
| Short-term Investments | · | · | · | · | · | $0 | · | $0 | · | $351.0K | $412.0K | $2M | · | · | $9M | $9M | |
| Receivables | $65.0K | $68.0K | $104.0K | $52.0K | $31.0K | $29.0K | $84.0K | $380.0K | $218.0K | $178.0K | $111.0K | $96.0K | $96.0K | $96.0K | $218.0K | · | |
| Prepaid Expense | $1M | $1M | $686.0K | $1M | $904.0K | $919.0K | $308.0K | $609.0K | $817.0K | $1M | $376.0K | $1M | $2M | $1M | $404.0K | $744.0K | |
| Current Assets | $11M | $17M | $5M | $10M | $11M | $15M | $20M | $24M | $13M | $4M | $6M | $5M | $10M | $15M | $20M | $23M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | $6M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $12.0K | $18.0K | $176.0K | $178.0K | $200.0K | $201.0K | $202.0K | $203.0K | $204.0K | $190.0K | $193.0K | · | · | · | $244.0K | · | |
| Total Assets | $15M | $21M | $10M | $16M | $17M | $21M | $26M | $30M | $19M | $10M | $12M | $12M | $17M | $22M | $27M | $31M | |
| Accounts Payable | $633.0K | $293.0K | $423.0K | $1M | $700.0K | $367.0K | $99.0K | $887.0K | $600.0K | $1M | $638.0K | $829.0K | $2M | · | $2M | $527.0K | |
| Accrued Liabilities | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $613.0K | $650.0K | $728.0K | |
| Current Liabilities | $4M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $5M | $4M | $3M | $4M | $4M | $5M | $4M | |
| Capital Leases | $0 | $60.0K | $169.0K | $336.0K | $501.0K | $664.0K | $824.0K | $983.0K | $1M | $1M | $1M | $2M | $2M | · | $2M | · | |
| Other Non-current Liabilities | $0 | $0 | $330.0K | $315.0K | $308.0K | $302.0K | $265.0K | $199.0K | $132.0K | $66.0K | $0 | · | · | · | · | · | |
| Total Liabilities | $5M | $5M | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $7M | $5M | $5M | $6M | $5M | $7M | $6M | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | · | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $153M | $153M | $138M | $137M | $132M | $132M | $131M | $131M | $116M | $92M | $92M | $86M | $85M | $84M | $84M | $83M | |
| Retained Earnings | $-143M | $-137M | $-132M | $-127M | $-120M | $-115M | $-110M | $-106M | $-101M | $-89M | $-85M | $-79M | $-73M | $-67M | $-63M | $-58M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| AOCI | · | · | · | · | · | · | · | $-1.0K | $-1.0K | $1.0K | · | $-309.0K | $-335.0K | $-299.0K | $-357.0K | · | |
| Stockholders' Equity | $10M | $16M | $6M | $10M | $13M | $17M | $22M | $26M | $15M | $3M | $7M | $7M | $11M | $16M | $21M | $25M | |
| Liabilities + Equity | $15M | $21M | $10M | $16M | $17M | $21M | $26M | $30M | $19M | $10M | $12M | $12M | $17M | $22M | $27M | $31M |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | |
| Stock-based Comp | $373.0K | $379.0K | $376.0K | $448.0K | $513.0K | $340.0K | $390.0K | $1M | $230.0K | $295.0K | $413.0K | $499.0K | $699.0K | $421.0K | $476.0K | · | |
| Amort. of Intangibles | $0 | $100.0K | $0 | $100.0K | $100.0K | $200.0K | $-300.0K | $100.0K | $300.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | |
| Other Non-cash | · | $-213.0K | · | · | · | $-226.0K | · | · | · | $477.0K | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-6M | $-4M | $-5M | $-5M | $-4M | $-5M | $-3M | $-3M | $-5M | $-3M | $-4M | $-5M | $-5M | $-6M | $-2M | $-4M | |
| CapEx | $103.0K | $0 | $0 | $57.0K | $161.0K | $27.0K | $13.0K | $430.0K | $196.0K | $16.0K | $164.0K | $3.0K | $92.0K | $42.0K | $66.0K | $378.0K | |
| Investing Cash Flow | $-103.0K | $-20.0K | $-64.0K | $-118.0K | $-263.0K | $-150.0K | $-123.0K | $-478.0K | $-53.0K | $14.0K | $2M | $4M | $2M | $346.0K | $-570.0K | $-2M | |
| Stock Issued | · | · | $836.0K | · | · | · | $0 | $8M | $5M | $100.0K | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $100.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $75.0K | $15M | $777.0K | $4M | $-133.0K | $-58.0K | $-50.0K | $14M | $15M | $63.0K | $5M | $-50.0K | $-86.0K | $-17.0K | $-193.0K | $-27.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-3M | · | · | · | $-6M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 66.3% | · | 91.2% | 46.2% | 72.2% | · | 88.2% | 73.5% | 60.0% | · | 36.0% | 42.9% | 27.2% | · | 34.7% | |
| Operating Margin | -2150.2% | -1199.8% | · | -5335.8% | -1707.9% | -1359.8% | · | -601.4% | -747.9% | -746.4% | · | -3440.7% | -2632.3% | -1690.3% | · | -1957.4% | |
| Net Margin | -2116.0% | -1190.0% | · | -5270.8% | -1591.1% | -1315.2% | · | -571.7% | -729.3% | -740.5% | · | -3404.0% | -2595.4% | -1665.6% | · | -1978.9% | |
| EBITDA Margin | -2080.5% | -1149.5% | · | -5189.8% | -1644.6% | -1307.3% | · | -601.4% | -705.1% | -709.8% | · | -3307.3% | -2540.1% | -1618.6% | · | -1881.9% | |
| ROA | -37.7% | -22.5% | · | -31.8% | -27.8% | -32.8% | · | -21.3% | -18.7% | -25.8% | · | -24.2% | -21.5% | -15.2% | · | -18.2% | |
| ROE | -52.7% | -28.5% | · | -40.6% | -36.5% | -49.6% | · | -27.4% | -26.1% | -41.9% | · | -32.7% | -27.7% | -18.4% | · | -22.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 3.9 | · | 2.1 | 3.4 | 5.6 | · | 7.7 | 4.2 | 0.7 | · | 1.5 | 2.5 | 4.1 | · | 6.3 | |
| Quick Ratio | 2.4 | 3.6 | · | 1.9 | 3.2 | 5.3 | · | 7.5 | 3.9 | 0.5 | · | 1.2 | 0.7 | 1.4 | · | 6.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 6.0 | 8.2 | · | 0.6 | 2.5 | 3.7 | · | 3.2 | 3.0 | 4.0 | · | 3.1 | 4.5 | 5.8 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $0.01 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.07 | $0.22 | · | $0.01 | $0.01 | $0.01 | · | $0.01 | |
| Cash Flow / Share | · | $-0.00 | · | · | · | $-0.00 | · | · | · | $-1.23 | · | · | · | $-0.28 | · | · | |
| EPS (TTM) | $-1.00 | $-1.14 | · | $0.10 | $0.15 | $-1.35 | · | $-6.33 | $-8.78 | $-9.62 | · | $-7.88 | $-5.34 | $-2.94 | · | $-0.89 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $1M | $2M | $2M | · | $2M | $1M | $978.0K | · | $767.0K | $882.0K | $1M | · | $1M | |
| Net Income TTM | $-23M | $-22M | · | $-21M | $-19M | $-17M | · | $-18M | $-19M | $-21M | · | $-20M | $-20M | $-20M | · | $-18M | |
| P/E | -0.7 | -0.9 | · | 7.5 | 8.7 | -1.1 | · | -0.3 | -0.2 | -0.3 | · | -3.0 | -6.3 | -9.1 | · | -41.6 | |
| Earnings Yield | -142.2% | -109.6% | · | 13.3% | 11.5% | -87.1% | · | -326.3% | -545.3% | -296.0% | · | -33.7% | -15.8% | -11.0% | · | -2.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $1M | $2M | $709.0K | $1M | $1M |
| Bruttogewinnmarge % | 67.0% | 78.8% | · | 40.7% | 45.2% |
| Betriebsgewinnmarge % | -1942.2% | -690.7% | · | -1476.5% | -1336.6% |
| Nettoergebnis | $-23M | $-16M | $-21M | $-19M | $-17M |
| Verwässerte EPS | $-1.29 | $-2.62 | $-10.22 | $-0.90 | $-0.90 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.3 | 7.6 | · | 4.2 | 13.1 |
| Quick Ratio | 1.2 | 7.5 | · | 2.2 | 13.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-19M | $-15M | · | $-15M | $-10M |
Institutionelle Eigentümer (13F) 41 Einreicher · $3.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
41
Gehaltener Wert
$3.6M
Neue Positionen
13
Geschlossene Positionen
5
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 13 (+2 vs. Vorquartal) | 5 (-4 vs. Vorquartal) | 7 (+4 vs. Vorquartal) | 3 (0 vs. Vorquartal) | +2.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $951.778 | 1.353.881 | 26,74% | Aktien |
| Logos Global Management LP | $904.761 | 1.287.000 | 25,42% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $408.657 | 581.305 | 11,48% | Aktien |
| VANGUARD GROUP INC | $252.558 | 499.126 | 7,10% | Aktien |
| BlackRock, Inc. | $157.592 | 224.170 | 4,43% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $143.244 | 203.761 | 4,03% | Aktien |
| JANE STREET GROUP, LLC | $133.831 | 190.370 | 3,76% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $98.509 | 140.127 | 2,77% | Aktien |
| Mariner, LLC | $88.578 | 126.000 | 2,49% | Aktien |
| ADAR1 Capital Management, LLC | $76.209 | 108.406 | 2,14% | Aktien |
| Beacon Pointe Advisors, LLC | $70.300 | 100.000 | 1,98% | Aktien |
| TWO SIGMA SECURITIES, LLC | $39.349 | 55.973 | 1,11% | Aktien |
| STATE STREET CORP | $31.902 | 45.380 | 0,90% | Aktien |
| NORTHERN TRUST CORP | $30.439 | 43.299 | 0,86% | Aktien |
| SCOTIA CAPITAL INC. | $21.090 | 30.000 | 0,59% | Aktien |
| Capital Investment Advisory Services, LLC | $18.647 | 26.525 | 0,52% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $17.680 | 25.155 | 0,50% | Aktien |
| Hamilton Point Investment Advisors, LLC | $15.780 | 22.446 | 0,44% | Aktien |
| MONETA GROUP INVESTMENT ADVISORS LLC | $14.974 | 21.300 | 0,42% | Aktien |
| XTX Topco Ltd | $14.452 | 20.558 | 0,41% | Aktien |
| ANCHYRA PARTNERS LLC | $14.060 | 20.000 | 0,40% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $13.938 | 19.827 | 0,39% | Aktien |
| Accelerate Investment Advisors LLC | $10.018 | 14.250 | 0,28% | Aktien |
| Valeo Financial Advisors, LLC | $7.640 | 10.867 | 0,21% | Aktien |
| Cambridge Financial Group, LLC | $7.382 | 10.500 | 0,21% | Aktien |
| Tower Research Capital LLC (TRC) | $5.922 | 8.424 | 0,17% | Aktien |
| MCGUIRE CAPITAL ADVISORS INC | $2.812 | 4.000 | 0,08% | Aktien |
| Steward Partners Investment Advisory, LLC | $1.673 | 2.380 | 0,05% | Aktien |
| OSAIC HOLDINGS, INC. | $1.400 | 2.000 | 0,04% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $930 | 1.300 | 0,03% | Aktien |
| Cornerstone Planning Group LLC | $705 | 1.125 | 0,02% | Aktien |
| WELLS FARGO & COMPANY/MN | $703 | 1.000 | 0,02% | Aktien |
| BARCLAYS PLC | $587 | 835 | 0,02% | Aktien |
| MORGAN STANLEY | $478 | 680 | 0,01% | Aktien |
| Allworth Financial LP | $92 | 130 | 0,00% | Aktien |
| Aventura Private Wealth, LLC | $55 | 78 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $42 | 60 | 0,00% | Aktien |
| Virtu Financial LLC | $41 | 58.583 | 0,00% | Aktien |
| UBS Group AG | $4 | 5 | 0,00% | Aktien |
| CWM, LLC | $3 | 3 | 0,00% | Aktien |
| HUNTINGTON NATIONAL BANK | $2 | 1 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Joshua M. Hare, M.D. (2) ×4 Einreichungen | 15. April 2024 | · | Erste Einreichung | · | SEC |
| DS MED LLC (2), Donald M. Soffer (2) ×2 Einreichungen | 25. Mai 2022 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 30 Insider · 12 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Stephen H Willard | Chief Executive Officer | 1. Juli 2026 F | 771.681 | 0 | 0 | $0 |
| James Nathaniel Powell | Chief Executive Officer | 2. Januar 2026 F | 125.593 | 0 | 0 | $0 |
| Mohamed Wa'El Ahmed Hashad | Chief Executive Officer | 15. Juli 2025 A | 420.904 | 0 | 0 | $0 |
| Geoff Green | CEO | 4. April 2022 F | 133.904 | 0 | 0 | $0 |
| Nirav S. Jhaveri | Chief Financial Officer | 17. August 2026 A | 300.000 | 0 | 0 | $0 |
| Lisa Locklear | Chief Financial Officer | 1. Juli 2026 F | 443.181 | 0 | 0 | $0 |
| James Clavijo | CFO and Treasurer | 29. Juni 2023 S | 47.303 | 0 | 0 | $0 |
| Devin Blass | CTO & SVP of CMC | 19. August 2026 A | 711.735 | 0 | 0 | $0 |
| Nataliya Agafonova | Chief Medical Officer | 19. August 2026 A | 716.914 | 0 | 0 | $0 |
| Paul T Lehr | General Counsel, Secretary | 19. August 2026 A | 861.423 | 0 | 0 | $0 |
| Joshua Hare | Chief Scientific Officer | 19. August 2026 A | 1.607.796 | 0 | 0 | $0 |
| Kwan-Hong Christopher Min | Chief Medical Officer | 4. April 2022 A | 151.978 | 0 | 0 | $0 |
| George A. Paletta Jr. | Direktor | 19. August 2026 A | 70.000 | 0 | 0 | $0 |
| Roger Joseph Hajjar | Direktor | 19. August 2026 A | 69.000 | 0 | 0 | $0 |
| Arjun Jj Desai | Direktor | 19. August 2026 A | 36.000 | 0 | 0 | $0 |
| Ursula Ungaro | Direktor | 19. August 2026 A | 77.000 | 0 | 0 | $0 |
| Rock Soffer | Direktor | 19. August 2026 A | 262.034 | 0 | 0 | $0 |
| Deborah Ascheim | Direktor | 19. August 2026 A | 36.000 | 0 | 0 | $0 |
| Leah Rush Cann | Direktor | 19. August 2026 A | 36.000 | 0 | 0 | $0 |
| Khoso Baluch | Direktor | 11. August 2025 P | 52.516 | 0 | 0 | $0 |
| Neha J. Motwani | Direktor | 15. Juli 2025 A | 33.000 | 0 | 0 | $0 |
| Richard N Kender | Direktor | 15. Juli 2025 A | 33.000 | 0 | 0 | $0 |
| Neil E Hare | Direktor | 15. August 2024 A | 29.352 | 0 | 0 | $0 |
| Cathy Ross | Direktor | 10. Januar 2024 P | 10.000 | 0 | 0 | $0 |
| Jeffrey Pfeffer | Direktor | 28. Dezember 2023 P | 15.000 | 0 | 0 | $0 |
| Douglas W Losordo | Direktor | 21. Dezember 2023 A | 5.000 | 0 | 0 | $0 |
| Todd C Girolamo | Direktor | 21. Dezember 2022 A | 5.000 | 0 | 0 | $0 |
| Donald M Soffer | Direktor | 21. Dezember 2022 A | 6.693.737 | 0 | 0 | $0 |
| Erin Borger | Direktor | 21. Dezember 2022 A | 0 | 0 | 0 | $0 |
| DS MED LLC | 10%-Eigentümer | 17. Mai 2022 J | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
LGVN Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 9 Analysten
KAUF
Median-Ziel
$61.25
+2274,0%
2 22,2%
Starker Kauf
5 55,6%
Kauf
2 22,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-10-03Mittelwert-Ziel $61.25 +2274,0%
← Unter allen Zielen
Aktueller Preis $2.58
Tief$42.50
Mittelwert$61.25
Hoch$80.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 12, 2026